Etomidate Injection, Solution
Product Images NDC 51662-1542

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Etomidate (NDC 51662-1542). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Serialized Labeling (51662 1542 1 Etomidate Injection Vial And Serilization Label)

ETOMIDATE injection, USP 40 mg per 20 mL (2 mg/mL) in a single-dose vial. The vial is clear glass with a gray stopper and blue flip-off cap. The label indicates it is for intravenous use only and is distributed by HF Acquisition Co LLC, DBA HealthFirst.*

FDA Label Image

Vial Label (51662 1542 1 Vial Label)

Label for Etomidate Injection, USP 40 mg per 20 mL (2 mg/mL) intravenous injection, solution. The label shows it is a single-dose vial, sterile and nonpyrogenic, distributed by AuroMedics Pharma LLC and made in India. It includes storage instructions and contains Etomidate USP 2 mg per mL with propylene glycol 35% v/v.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of etomidate, showing its molecular composition with labeled atoms and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.